HFpEF: How to diagnose
HFpEF: The essentials to know10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA
This video is part of an educational series of four lectures focussed on The Essentials to know about HFpEF. In this module, dr. Borlaug discusses the usefulness and limitations of different diagnostic approaches for HFpEF.
Video navigation menu
- Clinical diagnosis of HFpEF and case presentation 01:01
- Exercise hemodynamics to diagnose HFpEF 04:28
- Usefulness of NT-proBNP, echocardiography and cardiopulmonary exercise testing 06:00
- The H2FPEF score: A simplified, evidence-based approach to diagnosis 08:32
- Cardiac causes of dyspnea that may mimic HFpEF 10:23
This educational video is the second part of a series called "HFpEF: The essentials to know" that are aimed to give cardiologists and other health care professionals involved in the management of heart failure a well-balanced expert view on the current state of the art about the disease.
This recording was developed under auspices of PACE-cme in collaboration with IPCCS. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme or IPCCS..
Other topics covered in this series
Other lectures part of this educational series are:
- HFpEF: What is it & size of the problem - Prof. Adriaan Voors, MD, University Medical Center Groningen, The Netherlands
- What are the most likely pathophysiological mechanisms involved in HFpEF? - Prof. Carolyn S.P. Lam, MD, National Heart Centre Singapore
- Current and future clinical approaches to manage HFpEF - Prof. Burkert Pieske, MD, Charité University Medicine and German Heart Center, Berlin, Germany
Barry A. Borlaug, MD - Associate Professor of Medicine; Director, Circulatory Failure Research, Mayo Clinic, Rochester, MN, USA. Dr. Borlaug is a board certified cardiologist, specializing in heart failure and invasive hemodynamic assessment, where he cares for heart failure patients on a regular basis in both the clinics and hospital.
This educational series is funded by an unrestricted educational grant provided by Novartis.